Patent details

Basic Information

Publication number:

LUC00045

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP107471682

Legal Status:

Inactive

Application number:

LUC00045

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/14/937

Marketing Authorization Type:

Marketing Authorization Date:

15/06/2016

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

26/10/2017

First Marketing Authorization date:

15/06/2016

Grant date:

26/02/2018

Activation date:

Publication date:

03/11/2017

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

15/06/2031

SPC Extension Expiration:

15/06/2031

Rejection date:

Withdrawal date:

Owner

From:

26/10/2017

 

 

Name:

Roche Glycart AG

Address:

Wagistrasse 18, 8952 Schlieren-Zuerich, Switzerland (CH)

Agent

Name:

Office FREYLINGER S.A.

From:

26/10/2017

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2018/01

Publication date:

15/01/2018

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

SPC2

Bulletin edition number:

2018/04

Publication date:

23/03/2018

Description:

Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:

02/09/2030

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
03/11/2017	Outgoing Correspondence	1
26/02/2018	Publication	1
26/10/2017	General Document	2
26/10/2017	Application Form	4
03/11/2017	Publication	1
26/10/2017	General Document	57
26/02/2018	Certificate	1